Request Free Sample
×
Uveitis Drug Market
ID: MRFR/Pharma/37622-HCR
128 Pages
October 2025
Rapport d’étude de marché sur les médicaments contre l’uvéite par type de médicament (corticostéroïdes, médicaments immunosuppresseurs, produits biologiques, anti-inflammatoires non stéroïdiens), par voie d’administration (orale, intravitréenne, topique, sous-cutanée), par indication (uvéite antérieure, uvéite intermédiaire, uvéite postérieure, panuvéite), par canal de distribution (pharmacie hospitalière, pharmacie de détail, pharmacie en ligne) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie-Pacifique, Moyen-Orient et Afrique) - Prévisions jusqu'en 2034
Les principales entreprises du marché Uveitis Drug Market incluent
Portée du rapport
Laisser un commentaire
FAQs
What is the projected market valuation of the Uveitis Drug Market by 2035?
The Uveitis Drug Market is projected to reach a valuation of 6.207 USD Billion by 2035.
What was the market valuation of the Uveitis Drug Market in 2024?
In 2024, the Uveitis Drug Market was valued at 3.625 USD Billion.
What is the expected CAGR for the Uveitis Drug Market during the forecast period 2025 - 2035?
The expected CAGR for the Uveitis Drug Market during the forecast period 2025 - 2035 is 5.01%.
Which companies are considered key players in the Uveitis Drug Market?
Key players in the Uveitis Drug Market include Novartis, Bristol-Myers Squibb, AbbVie, and Regeneron Pharmaceuticals.
What are the main drug types contributing to the Uveitis Drug Market?
The main drug types include Corticosteroids, Immunosuppressive Drugs, Biologics, and Non-Steroidal Anti-Inflammatory Drugs.
How did the market for Corticosteroids perform in 2024?
In 2024, the market for Corticosteroids was valued at 1.2 USD Billion and is expected to grow to 2.0 USD Billion by 2035.
What is the distribution channel with the highest projected growth in the Uveitis Drug Market?
The Online Pharmacy distribution channel is projected to grow from 1.425 USD Billion in 2024 to 2.407 USD Billion by 2035.
Which route of administration is expected to see the most significant increase in market value?
The Intravitreous route of administration is expected to increase from 1.125 USD Billion in 2024 to 1.845 USD Billion by 2035.
What indications are covered in the Uveitis Drug Market?
The Uveitis Drug Market covers indications such as Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, and Panuveitis.
How does the market for Posterior Uveitis compare to other indications in 2024?
In 2024, the market for Posterior Uveitis was valued at 1.0 USD Billion, indicating a competitive position among other indications.
Télécharger l'échantillon gratuit
Veuillez remplir le formulaire ci-dessous pour recevoir un échantillon gratuit de ce rapport
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Étude de cas
Aerospace & Defense